Your browser doesn't support javascript.
loading
Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma.
Orlando, Ida; Vitale, Antonio; Rigante, Donato; Lopalco, Giuseppe; Fabiani, Claudia; Cantarini, Luca.
Afiliação
  • Orlando I; Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
  • Vitale A; Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
  • Rigante D; Institute of Pediatrics, Catholic University of the Sacred Heart, A. Gemelli Hospital, Rome, Italy.
  • Lopalco G; Interdisciplinary Department of Medicine, Rheumatology Unit, Bari, Italy.
  • Fabiani C; Department of Ophthalmology, Humanitas Clinical and Research Center, Milan, Italy.
  • Cantarini L; Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
Intern Med J ; 47(9): 1086-1088, 2017 09.
Article em En | MEDLINE | ID: mdl-28891187
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Uveíte / Carcinoma Papilar / Síndrome de Behçet / Interleucina-1 / Antirreumáticos / Proteína Antagonista do Receptor de Interleucina 1 / Anticorpos Monoclonais Limite: Humans / Male / Middle aged Idioma: En Revista: Intern Med J Assunto da revista: MEDICINA INTERNA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Uveíte / Carcinoma Papilar / Síndrome de Behçet / Interleucina-1 / Antirreumáticos / Proteína Antagonista do Receptor de Interleucina 1 / Anticorpos Monoclonais Limite: Humans / Male / Middle aged Idioma: En Revista: Intern Med J Assunto da revista: MEDICINA INTERNA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália